Tenderwize
Retour à la recherche

Open House Discount Contracts for Tofacitinib, ATC L04AF01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 131 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tofacitinib , ATC L04AF01

25/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

25 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume provided; actual business may be negligible.

Buyer reserves the right to replace open house contracts with exclusive contracts, automatically terminating open house...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Tofacitinib (ATC L04AF01)
  • Open house model: any qualifying pharmaceutical company can join at any time
Afficher le résumé complet

AOK Rheinland-Pfalz/Saarland is offering non-exclusive discount contracts for the active substance Tofacitinib (ATC L04AF01) under an open house model. All interested pharmaceutical companies can join by submitting required documents. Contracts run from May 2025 to April 2027, with possible monthly entry. No estimated value is provided. The procedure is explicitly stated not to be a public procurement under EU directives.

Risques

No estimated value or volume provided; actual business may be negligible.

Buyer reserves the right to replace open house contracts with exclusive contracts, automatically terminating open house...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical company with authorized and marketable medicines in Germany
  • Medicines must be listed in Lauer-Taxe or proven via AMIce database extracts

Administrative

  • Submit signed contract documents by specified deadlines for desired start date

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Contracts for Tofacitinib, ATC L04AF01

Non-exclusive discount contracts for Tofacitinib under an open house model. All interested pharmaceutical companies can enter at any time during the 24-month period. Contracts are non-negotiable, standard terms. Early termination possible if exclusive contracts are concluded.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
164834-2025

Documents (1)

Appels d'offres similaires